Workshop on Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework, 40862 [2021-16118]
Download as PDF
<![CDATA[
40862
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16160 Filed 7–28–21; 8:45 am]
https://www.nichd.nih.gov/about/
meetings/2021/092321.
Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver
National Institute of Child Health and Human
Development, National Institutes of Health.
[FR Doc. 2021–16118 Filed 7–28–21; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Workshop on Exploring the Science
Surrounding the Safe Use of Bioactive
Ingredients in Infant Formula:
Considerations for an Assessment
Framework
National Institutes of Health,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
This 2-day, virtual
workshop—Exploring the Science
Surrounding the Safe Use of Bioactive
Ingredients in Infant Formula:
Considerations for an Assessment
Framework—focuses on the functional
state-of-the-science of biologically active
human milk components and analogs
and the implications for safety
assessments when used in infant
formula.
SUMMARY:
The Meeting will be held on
September 23–24, 2021, from 10:30 a.m.
to 4:30 p.m. (ET).
ADDRESSES: This workshop will be
videocast at https://videocast.nih.gov.
FOR FURTHER INFORMATION CONTACT: For
information concerning this meeting,
contract Dr. Ashley Vargas, Pediatric
Growth and Nutrition Branch, Division
of Extramural Research, Eunice Kennedy
Shriver National Institute of Child
Health and Human Development, 6701B
Rockledge Drive, Room 2423C,
Bethesda, MD 20817, telephone: 301–
827–6030, email: ashley.vargas@
nih.gov.
DATES:
This
Federal Register notice is in accordance
with 42 U.S.C. 285g, of the Public
Health Service Act, as amended. This
workshop is led by the Eunice Kennedy
Shriver National Institute of Child
Health and Human Development
(NICHD), the National Institutes of
Health (NIH) Office of Dietary
Supplements (ODS), and the Food and
Drug Administration (FDA). The
workshop is free and open to the public.
The workshop will be livestreamed, and
the video will be archived. Registration
will be available for this meeting at
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; IMAT
Biospecimen Research.
Date: September 30, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–2: NCI
Clinical and Translational Cancer Research.
Date: October 20–21, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20850, 240–276–7286, salvucco@
mail.nih.gov.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Initial Review Group; Transition to
Independence Study Section (I).
Date: October 20–21, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W602, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Delia Tang, M.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W602, Rockville, Maryland 20850,
240–276–6456, tangd@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–3: NCI
Clinical and Translational Cancer Research.
Date: October 21–22, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Shuli Xia, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W102, Rockville, Maryland 20850,
shuli.xia@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–8: NCI
Clinical and Translational Cancer Research.
Date: November 4–5, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Susan Lynn Spence, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W126, Rockville, Maryland
20850, susan.spence@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4: NCI
Clinical and Translational Cancer Research.
Date: November 4–5, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W254, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Rockville, Maryland
20850, 240–276–7975, chufanee@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Page 40862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Workshop on Exploring the Science Surrounding the Safe Use of
Bioactive Ingredients in Infant Formula: Considerations for an
Assessment Framework
AGENCY: National Institutes of Health, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This 2-day, virtual workshop--Exploring the Science
Surrounding the Safe Use of Bioactive Ingredients in Infant Formula:
Considerations for an Assessment Framework--focuses on the functional
state-of-the-science of biologically active human milk components and
analogs and the implications for safety assessments when used in infant
formula.
DATES: The Meeting will be held on September 23-24, 2021, from 10:30
a.m. to 4:30 p.m. (ET).
ADDRESSES: This workshop will be videocast at https://videocast.nih.gov.
FOR FURTHER INFORMATION CONTACT: For information concerning this
meeting, contract Dr. Ashley Vargas, Pediatric Growth and Nutrition
Branch, Division of Extramural Research, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, 6701B
Rockledge Drive, Room 2423C, Bethesda, MD 20817, telephone: 301-827-
6030, email: [email protected].
SUPPLEMENTARY INFORMATION: This Federal Register notice is in
accordance with 42 U.S.C. 285g, of the Public Health Service Act, as
amended. This workshop is led by the Eunice Kennedy Shriver National
Institute of Child Health and Human Development (NICHD), the National
Institutes of Health (NIH) Office of Dietary Supplements (ODS), and the
Food and Drug Administration (FDA). The workshop is free and open to
the public. The workshop will be livestreamed, and the video will be
archived. Registration will be available for this meeting at https://www.nichd.nih.gov/about/meetings/2021/092321.
Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver National Institute of Child
Health and Human Development, National Institutes of Health.
[FR Doc. 2021-16118 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P
